Federal grants to Phagepro, P.B.C.
Phagepro, P.B.C. in Mansfield, Massachusetts received $4.5 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Allergy and Infectious Diseases Research, with $4.5 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.5 million
- Awards4
- Awarded in FY 2025$1.0 million
- Largest award$2.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.2 million |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 1 | $930,046 |
| FY 2024 | 1 | $173,300 |
| FY 2025 | 1 | $1.0 million |
Programs that fund Phagepro, P.B.C.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 4 | $4.5 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $4.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings - project summary cholera is an acute and severe disease caused by the bacterium vibrio cholerae that is spread primarily through contaminated water sources due to a lack of adequate san | Allergy and Infectious Diseases Research | February 11, 2021 | $2.9 million |
| Manufacturing and formulation process development for a prophylactic cholera phage cocktail - project summary the world health organization (WHO) estimates that approximately 1.3 billion people globally are at risk for cholera, a severe diarrheal disease caused by the bacterium vibrio cholerae that | Allergy and Infectious Diseases Research | December 16, 2024 | $1.0 million |
| Targeting antibiotic resistance genes in vibrio cholerae using a phage-encoded crispr-cas system to improve efficacy of phage prophylaxis - project summary the incessant rise of multidrug resistance in bacterial pathogens has created a dire situation that necessitates development of new modalities f | Allergy and Infectious Diseases Research | December 18, 2020 | $383,168 |
| Preparation of a phase i/II safety and efficacy trial for a cholera phage cocktail intervention - project summary the world health organization (WHO) estimates that approximately 1.3 billion people globally are at risk for cholera, a severe diarrheal disease caused by the bacterium vibrio cholerae t | Allergy and Infectious Diseases Research | July 17, 2024 | $173,300 |
Questions people ask
How much federal grant money does Phagepro, P.B.C. get?
$4.5 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Phagepro, P.B.C. the most?
The Department of Health and Human Services, with $4.5 million in 4 awards.
What is Phagepro, P.B.C.'s largest federal grant?
$2.9 million under Allergy and Infectious Diseases Research, with its first action in the period on February 11, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Mansfield
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts